Nonprescription syringe sales: A missed opportunity for HIV prevention in California

Journal of the American Pharmacists Association

Volumn 55, Issue 1, 2015, Pages 31-40

  Pollini, Robin A ^a   Rudolph, Abby E ^a   Case, Patricia ^b  

^a PACIFIC INSTITUTE FOR RESEARCH AND EVALUATION   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DISEASE TRANSMISSION; FEMALE; GEOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INTRAVENOUS DRUG ABUSE; LEGAL ASPECT; MALE; MARKETING; NONPRESCRIPTION SYRINGE; OUTCOME ASSESSMENT; OUTCOME VARIABLE; PHARMACY; PRESCRIPTION; PREVALENCE; SYRINGE; UNITED STATES; ATTITUDE TO HEALTH; CALIFORNIA; CLINICAL COMPETENCE; COMMERCIAL PHENOMENA; ECONOMICS; HEALTH CARE DELIVERY; HEALTH PERSONNEL ATTITUDE; HIV INFECTIONS; LEGISLATION AND JURISPRUDENCE; PHARMACIST; PROFESSIONAL STANDARD; PSYCHOLOGY; SUBSTANCE ABUSE; TRANSMISSION;

ATTITUDE OF HEALTH PERSONNEL; CALIFORNIA; CLINICAL COMPETENCE; COMMERCE; COMMUNITY PHARMACY SERVICES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; PHARMACISTS; PROFESSIONAL ROLE; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES;

EID: 84920970031     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2015.14148     Document Type: Article

References (40)

1. Centers for Disease Control and Prevention. Epidemiology of HIV infection through 2011. Accessed at http://www.cdc.gov/hiv/pdf/statistics-surveillance-Epi-HIV-infection.pdf.
2. Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data - United States and 6 US dependent areas - 2010. HIV AIDS Surveill Rep. 2012;17(3).
3. US Public Health Service. HIV prevention bulletin: medical advice for persons who inject illicit drugs. May 9, 1997. Rockville, MD; 1997.
4. Des Jarlais DC, Guardino V, Nugent A et al. 2011 National Survey of Syringe Exchange Programs: Summary of Results. Accessed at http://www.nasen.org/news/2012/nov/29/2011-bethisrael-survey-results-summary/.
5. Mathers BM, Degenhardt L, Ali H et al. HIV prevention, treatment, and care services for people who inject drugs: A systematic review of global, regional, and national coverage. Lancet. 2010;375(9719):1014-1028.
6. Cotton-Oldenburg NU, Carr P, DeBoer JM et al. Impact of pharmacy- based syringe access on injection practices among injection drug users in Minnesota, 1998 to 1999. J Acquir Immune Defic Syndr. 2001;27:183-192.
7. Groseclose SL, Weinstein B, Jones TS et al. Impact of increased legal access to needles and syringes on practices of injectingdrug users and police officers - Connecticut, 1992-1993. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10(1):82-89.
8. Lutnick A, Cooper E, Dodson C et al. Pharmacy Syringe Purchase Test of Nonprescription Syringe Sales in San Francisco and Los Angeles in 2010. J Urban Health. 2013;90(2):276-283.
9. Compton WM, Horton JC, Cottler LB et al. A multistate trial of pharmacy syringe purchase. J Urban Health. 2004;81(4):661-670.
10. Deibert RJ, Goldbaum G, Parker TR et al. Increased access to pharmacy sales of syringes in Seattle-King County, Washington: Structural and individual-level changes, 1996 versus 2003. Am J Public Health. 2006;96:1347-1353.
11. Finkelstein R, Tiger R, Greenwald R et al. Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001-2002). J Am Pharm Assoc (Wash). 2002;42(6 suppl 2):S83-S87.
12. Koester SK, Bush TW, Lewis BA. Limited access to syringes for injection drug users in pharmacies in Denver, Colorado. J Am Pharm Assoc (Wash). 2002;42(6 suppl 2):S88-S91.
13. Trubatch BN, Fisher DG, Cagle HH et al. Nonprescription pharmacy sales of needles and syringes. Am J Public Health. 2000;90(10):1639-1640.
14. Blumenthal WJ, Springer KW, Jones TS et al. Pharmacy student knowledge, attitudes, and beliefs about selling syringes to injection drug users. J Am Pharm Assoc. 2002;42(6 suppl 2):S34-S39.
15. Singer M, Baer HA, Scott G et al. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut. Public Health Rep. 1998;133(suppl 1):81-89.
16. Farley TA, Niccolai LM, Billeter M et al. Attitudes and practices of pharmacy managers regarding needle sales to injection drug users. J Am Pharm Assoc (Wash). 1999;39(Jan-Feb):23-26.
17. Marks RW, Hanrahan M, Williams DH et al. Encouraging pharmacy sale and safe disposal of syringes in Seattle, Washington. J Am Pharm Assoc (Wash). 2002;42(6 suppl 2):S26-S27.
18. Wright-De Aguero L, Weinstein B, Jones TS et al. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(suppl 1):S102-S110.
19. Taussig J, Junge B, Burris S et al. Individual and structural influences in shaping pharmacists' decisions to sell syringes to injection drug users in Atlanta, Georgia. J Am Pharm Assoc. 2002;42(6 suppl 2):S40-S45.
20. Lewis BA, Koester SK, Bush TW. Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado. J Am Pharm Assoc (Wash). 2002;42(6 suppl 2):S46-S51.
21. California Department of Public Health Office of AIDS. HIV/ AIDS surveillance in California. Accessed at http://www.cdph.ca.gov/programs/aids/Documents/June-2013-Semi%20Annual%20Report.pdf.
22. California Department of Public Health. Chronic hepatitis B and hepatitis C infections in California: cases newly reported through 2011. Sacramento, CA; 2013.
23. Garfein RS, Stopka TJ, Pavlinac PB et al. Three years after legalization of nonprescription pharmacy syringe sales in California: where are we now? J Urban Health. 2010;87(4):576-585.
24. Cooper EN, Dodson C, Stopka TJ et al. Pharmacy participation in non-prescription syringe sales in Los Angeles and San Francisco counties, 2007. J Urban Health. 2010;87(4):543-552.
25. Stopka TJ, Garfein R, Riley E et al. SB 1159 report: an evaluation of over-the-counter sale of sterile syringes in California. Sacramento, CA; 2010:96.
26. Brady JE, Friedman SR, Cooper HL et al. Estimating the prevalence of injection drug users in the US and in large US metropolitan areas from 1992 to 2002. J Urban Health. 2008;85(3):323-351.
27. California Department of Public Health. Cumulative reported AIDS February 1, 1983-December 31, 2013. Accessed at http://www.co.fresno.ca.us/uploadedFiles/Departments/Public-Health/Divisions/CH/content/CD/content/Epidemiology/2013/AIDS%204th%20QTR%202013.pdf.
28. Kern County Public Health Services Department. HIV/AIDS service delivery plan. Bakersfield, CA; 2013.
29. Pollini RA, Rosen PC, Gallardo M et al. Not sold here: limited access to legally available syringes at pharmacies in Tijuana, Mexico. Harm Reduct J. 2011;8(1):13.
30. Fedorova EV, Skochilov RV, Heimer R et al. Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study. BMC Public Health. 2013;13(1):1-7.
31. Pendragon Software Corporation Pendragon Forms VI. Buffalo Grove, IL: Pendragon Software Corporation; 2011.
32. ESRI North America detailed streets. Redlands, CA; 2007.
33. Yang D-H, Goerge R, Mullner R. Comparing GIS-based methods of measuring spatial accessibility to health services. J Med Syst. 2006;30(1):23-32.
34. Delamater PL, Messina JP, Shortridge AM et al. Measuring geographic access to health care: raster and network-based methods. Int J Health Geogr. 2012;11(1):15.
35. California Department of Public Health. Materials for pharmacists and health departments - nonprescription sale of syringes. Accessed at http://www.cdph.ca.gov/programs/aids/Pages/OASAMaterials.aspx.
36. Case P, Beckett GA, Jones TS. Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(suppl 1):S94-S101.
37. Reich W, Compton WM, Horton JC et al. Injection drug users report good access to pharmacy sale of syringes. J Am Pharm Assoc (2003). 2002;42(6 suppl 2):S68-S72.
38. Davidson PJ, Lozada R, Rosen PC et al. Negotiating access: social barriers to purchasing syringes at pharmacies in Tijuana, Mexico. Int J Drug Policy. 2012;23(4):286-294.
39. Zaller ND, Yokell MA, Apeakorang N et al. Reported experiences during syringe purchases in Providence, Rhode Island: implications for HIV prevention. J Health Care Poor Underserved. 2012;23(3):1310-1326.
40. Pollini RA, Lozada R, Gallardo M et al. Barriers to pharmacybased syringe purchase among injection drug users in Tijuana, Mexico: a mixed methods study. AIDS Behav. 2010;14(3):679-687.